Abstract
The purpose of this study is to assess the diagnosis, treatment and prognosis of the dentinogenic ghost cell tumor (DGCT). This is a retrospective study of patients with DGCT who underwent one or multiple surgical interventions during the 10-year period from 1997 to 2007. Seven patients with DGCT were identified under the WHO 2005 classification guidelines. The lesions were located in the maxilla in 4 patients and in the mandible in 3 patients. Five patients experienced recurrences following conservative surgery. They were all treated with aggressive local resection. Two patients had no conservative surgery but aggressive local resection. After 7-105 months' follow-up, no recurrences were found in any of the patients. Intraosseous DGCT should be treated by resection with an adequate safety margin, of at least 0.5 cm, as recommended for ameloblastoma. Patients with a DGCT should remain in long-term follow-up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Oral and Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
